Halaven: payments to doctors
Payments that named Halaven as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $708K
- Providers
- 1,658
- Transactions
- 2,988
- Average per transaction
- $237
The per-transaction average — $237 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,658 providers the average total is $427, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Eisai Inc. | $608,910 | 86.0% |
| Eisai Co., Ltd. | $99,141 | 14.0% |